DE69426275D1 - Clarazell-Protein CC10 enthaltendes pharmazeutisches Präparat und seine Verwendung als Arzneimittel und Diagnostikum - Google Patents

Clarazell-Protein CC10 enthaltendes pharmazeutisches Präparat und seine Verwendung als Arzneimittel und Diagnostikum

Info

Publication number
DE69426275D1
DE69426275D1 DE69426275T DE69426275T DE69426275D1 DE 69426275 D1 DE69426275 D1 DE 69426275D1 DE 69426275 T DE69426275 T DE 69426275T DE 69426275 T DE69426275 T DE 69426275T DE 69426275 D1 DE69426275 D1 DE 69426275D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
preparation containing
protein
clarazell
diagnostic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426275T
Other languages
English (en)
Other versions
DE69426275T2 (de
Inventor
Marc Jozef Ph De Ley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69426275D1 publication Critical patent/DE69426275D1/de
Application granted granted Critical
Publication of DE69426275T2 publication Critical patent/DE69426275T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69426275T 1993-03-15 1994-03-14 Clarazell-Protein CC10 enthaltendes pharmazeutisches Präparat und seine Verwendung als Arzneimittel und Diagnostikum Expired - Fee Related DE69426275T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9300242A BE1006919A3 (nl) 1993-03-15 1993-03-15 Farmaceutisch preparaat op basis van clara celeiwit cc10, en het gebruik daarvan als geneesmiddel en diagnosticum.

Publications (2)

Publication Number Publication Date
DE69426275D1 true DE69426275D1 (de) 2000-12-21
DE69426275T2 DE69426275T2 (de) 2001-06-07

Family

ID=3886902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426275T Expired - Fee Related DE69426275T2 (de) 1993-03-15 1994-03-14 Clarazell-Protein CC10 enthaltendes pharmazeutisches Präparat und seine Verwendung als Arzneimittel und Diagnostikum

Country Status (8)

Country Link
EP (1) EP0617965B1 (de)
AT (1) ATE197548T1 (de)
BE (1) BE1006919A3 (de)
DE (1) DE69426275T2 (de)
DK (1) DK0617965T3 (de)
ES (1) ES2152285T3 (de)
GR (1) GR3035386T3 (de)
PT (1) PT617965E (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509316B2 (en) * 1995-03-07 2003-01-21 George Washington University Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
US6255281B1 (en) 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
WO2000072868A2 (en) * 1999-06-01 2000-12-07 Prendergast Patrick T Peptides for therapeutic use
US9394349B2 (en) 2013-03-15 2016-07-19 Therabron Therapeutics, Inc. Modification and compositions of human secretoglobin proteins
WO2023212398A1 (en) * 2022-04-29 2023-11-02 Apc Research Assets Llc Secretoglobins for suppression of antibody responses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266562A (en) * 1987-11-19 1993-11-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-inflammatory agents

Also Published As

Publication number Publication date
ATE197548T1 (de) 2000-12-15
PT617965E (pt) 2001-03-30
GR3035386T3 (en) 2001-05-31
EP0617965A1 (de) 1994-10-05
ES2152285T3 (es) 2001-02-01
BE1006919A3 (nl) 1995-01-24
EP0617965B1 (de) 2000-11-15
DE69426275T2 (de) 2001-06-07
DK0617965T3 (da) 2001-02-05

Similar Documents

Publication Publication Date Title
DE58909793D1 (de) Neue Benzopyran-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltenden Zubereitungen
NO306346B1 (no) N-substituerte azabicykloalkanderivater, anvendelse derav og farmasöytisk preparat
IL127296A0 (en) Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
ES2153975T3 (es) Derivados de pirimidona con actividad antifungica.
IE891542L (en) Peptides having t cell helper activity
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
CA2173963A1 (en) Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
AU2673095A (en) {a}-annelated pyrrole derivatives and pharmaceutical use thereof
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
DE69426275D1 (de) Clarazell-Protein CC10 enthaltendes pharmazeutisches Präparat und seine Verwendung als Arzneimittel und Diagnostikum
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
DK0723544T3 (da) Alkoxyalkylcarbamater af imidazo[1,2-a]pyridiner
ATE49970T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
BR9408244A (pt) Derivados de azabiciclo[3.2.0]heptano N-substituídos
ATE66230T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
DE58909594D1 (de) 6-Oxo-pyridazinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
ATE23719T1 (de) Rifamycinderivate, herstellung und diese enthaltende pharmazeutische zubereitungen.
IL107232A0 (en) 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
ES2126577T3 (es) Analogos alquilidenicos de 1'-aminoespiro(isoquinolino-4(1h),3'-pirrolidino)-1,2',3,5'(2h)-tetronas utiles como inhibidores de la aldosa reductasa in vivo.
ATE192164T1 (de) Synthetische peptide und diese enthaltende pharmazeutische zusammensetzungen
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.
IT1276706B1 (it) Bicarbonati di derivati della 2,6-dimetilanilina, loro uso in terapia e composizioni farmaceutiche che li comprendono
IT1262569B (it) Derivati tetraciclici diazepinici, loro processi di preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee